Page last updated: 2024-08-23

1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril and Diffuse Mixed Small and Large Cell Lymphoma

1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baars, JW; Beijnen, JH; Hoefnagel, CA; Huitema, AD; Maessen, HJ; Tran, L1

Other Studies

1 other study(ies) available for 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
A simple and safe method for 131I radiolabeling of rituximab for myeloablative high-dose radioimmunotherapy.
    Cancer biotherapy & radiopharmaceuticals, 2009, Volume: 24, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Equipment Design; Humans; Iodine Radioisotopes; Lymphoma, Non-Hodgkin; Mice; Protein Binding; Quality Control; Radiation Protection; Radioimmunotherapy; Radiopharmaceuticals; Rituximab; Urea

2009